Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,076.39, with a market capitalization of 1.02T. The stock trades at a price-to-earnings (P/E) ratio of 53.35 and offers a dividend yield of 55.6%.
As of 2025-12-31, Eli Lilly(LLY) stock has fluctuated between $1,074.49 and $1,083.37. The current price stands at $1,076.39, placing the stock +0.2% above today's low and -0.6% off the high.
Eli Lilly(LLY) shares are trading with a volume of 796.08K, against a daily average of 2.7M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Biotech and Pharma In the Year of the Weight-Loss Pill, Lilly Still Leads GLP-1s In this article NOVO.B LLY Novo Nordisk and Eli Lilly will introduce pill versi...
Dow Jones Futures Fall On 2025's Final Day; Eli Lilly, Shopify Forge Buy Points 12/30/2025 The stock market will enter the final day of 2025 near highs — and k...
The stock already looks unstoppable, and this move won't hurt its momentum. Everything seems to be going well for Eli Lilly (LLY 0.05%). The company's shares h...
Analyst ratings
80%
of 30 ratingsMore LLY News
New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on December 30, 2025. Claim 70% Off TipRanks This Holiday Season Unlock hedge fund-level data a...
Key Points Novo Nordisk's CagriSema could be a brand new growth driver for the company. Eli Lilly's orforglipron is breaking into a new, lucrative market. On...
Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026 Quick Read Eli Lilly ( LLY ) achieved 54% year-over-year revenue growth to $17.6B i...
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Twin Momentum Investor m...
Key Points This pharma player offers you safety and growth. The company is a leader in a market that may approach $100 billion by the end of the decade. 10 s...
(RTTNews) - ABL Bio Inc. (298380.KQ), a South Korean biotechnology company, on Friday said it has secured a total of $55 million in research and development fun...
CRISPR Therapeutics (CRSP) just gave investors a fresh update on zugo cel, its off the shelf CAR T therapy, highlighting strong early responses, clean safety si...
